These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 24311528
1. Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. Min Y, Li J, Liu F, Yeow EK, Xing B. Angew Chem Int Ed Engl; 2014 Jan 20; 53(4):1012-6. PubMed ID: 24311528 [Abstract] [Full Text] [Related]
2. Human transport protein carrier for controlled photoactivation of antitumor prodrug and real-time intracellular tumor imaging. Li X, Mu J, Liu F, Tan EW, Khezri B, Webster RD, Yeow EK, Xing B. Bioconjug Chem; 2015 May 20; 26(5):955-61. PubMed ID: 25938732 [Abstract] [Full Text] [Related]
3. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood. Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR. Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446 [Abstract] [Full Text] [Related]
4. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs. Ravera M, Perin E, Gabano E, Zanellato I, Panzarasa G, Sparnacci K, Laus M, Osella D. J Inorg Biochem; 2015 Oct 23; 151():132-42. PubMed ID: 26277416 [Abstract] [Full Text] [Related]
5. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin. Ma R, Wang Y, Yan L, Ma L, Wang Z, Chan HC, Chiu SK, Chen X, Zhu G. Chem Commun (Camb); 2015 May 07; 51(37):7859-62. PubMed ID: 25854514 [Abstract] [Full Text] [Related]
6. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy. Xiao H, Yan L, Zhang Y, Qi R, Li W, Wang R, Liu S, Huang Y, Li Y, Jing X. Chem Commun (Camb); 2012 Nov 11; 48(87):10730-2. PubMed ID: 23012698 [Abstract] [Full Text] [Related]
7. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance. Ai F, Sun T, Xu Z, Wang Z, Kong W, To MW, Wang F, Zhu G. Dalton Trans; 2016 Aug 16; 45(33):13052-60. PubMed ID: 27430044 [Abstract] [Full Text] [Related]
8. Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug. Ma L, Wang N, Ma R, Li C, Xu Z, Tse MK, Zhu G. Angew Chem Int Ed Engl; 2018 Jul 16; 57(29):9098-9102. PubMed ID: 29806087 [Abstract] [Full Text] [Related]
9. Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug. Ravera M, Gabano E, Bonzani D, Zanellato I, Arrais A, Cantamessa S, Biggiogera M, Osella D. J Inorg Biochem; 2018 Dec 16; 189():185-191. PubMed ID: 30312905 [Abstract] [Full Text] [Related]
10. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin. Shi H, Cheng Q, Yuan S, Ding X, Liu Y. Chemistry; 2015 Nov 09; 21(46):16547-54. PubMed ID: 26405808 [Abstract] [Full Text] [Related]
11. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin. Shi Y, Goodisman J, Dabrowiak JC. Inorg Chem; 2013 Aug 19; 52(16):9418-26. PubMed ID: 23889547 [Abstract] [Full Text] [Related]
12. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon. Yue Z, Wang H, Li Y, Qin Y, Xu L, Bowers DJ, Gangoda M, Li X, Yang HB, Zheng YR. Chem Commun (Camb); 2018 Jan 18; 54(7):731-734. PubMed ID: 29303526 [Abstract] [Full Text] [Related]
13. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. Yuan Y, Kwok RT, Tang BZ, Liu B. J Am Chem Soc; 2014 Feb 12; 136(6):2546-54. PubMed ID: 24437551 [Abstract] [Full Text] [Related]
14. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo. Ma ZY, Wang DB, Song XQ, Wu YG, Chen Q, Zhao CL, Li JY, Cheng SH, Xu JY. Eur J Med Chem; 2018 Sep 05; 157():1292-1299. PubMed ID: 30195239 [Abstract] [Full Text] [Related]
15. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity. Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H. Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585 [Abstract] [Full Text] [Related]
16. NIR Light and GSH Dual-Responsive Upconversion Nanoparticles Loaded with Multifunctional Platinum(IV) Prodrug and RGD Peptide for Precise Cancer Therapy. Liu XM, Zhu ZZ, He XR, Zou YH, Chen Q, Wang XY, Liu HM, Qiao X, Wang X, Xu JY. ACS Appl Mater Interfaces; 2024 Aug 07; 16(31):40753-40766. PubMed ID: 39046129 [Abstract] [Full Text] [Related]
17. A platinum prodrug conjugated with a photosensitizer with aggregation-induced emission (AIE) characteristics for drug activation monitoring and combinatorial photodynamic-chemotherapy against cisplatin resistant cancer cells. Yuan Y, Zhang CJ, Liu B. Chem Commun (Camb); 2015 May 21; 51(41):8626-9. PubMed ID: 25898264 [Abstract] [Full Text] [Related]
19. Near-Infrared Light-Triggered Sulfur Dioxide Gas Therapy of Cancer. Li S, Liu R, Jiang X, Qiu Y, Song X, Huang G, Fu N, Lin L, Song J, Chen X, Yang H. ACS Nano; 2019 Feb 26; 13(2):2103-2113. PubMed ID: 30642157 [Abstract] [Full Text] [Related]
20. One-pot synthesis of SiO2-coated Gd2(WO4)3:Yb3+/Ho3+ nanoparticles for simultaneous multi-imaging, temperature sensing and tumor inhibition. Liu G, Chen Y, Jia M, Sun Z, Ding B, Shao S, Jiang F, Fu Z, Ma P, Lin J. Dalton Trans; 2019 Jul 16; 48(28):10537-10546. PubMed ID: 31214676 [Abstract] [Full Text] [Related] Page: [Next] [New Search]